छोड़कर सामग्री पर जाएँ
Easy Trip Planners gets board nod for raising funds up to Rs 1,000 crore

Easy Trip Planners gets board nod for raising funds up to Rs 1,000 crore

The board of directors of the company, at its meeting held on Tuesday, has given in-principle approval for the fundraising proposal, Easy Trip Planners, which operates under the brand EaseMyTrip, the company said in a regulatory filing.

Read More

​ The board of directors of the company, at its meeting held on Tuesday, has given in-principle approval for the fundraising proposal, Easy Trip Planners, which operates under the brand EaseMyTrip, the company said in a regulatory filing. The board of directors of the company, at its meeting held on Tuesday, has given in-principle approval for the fundraising proposal, Easy Trip Planners, which operates under the brand EaseMyTrip, the company said in a regulatory filing.  Moneycontrol Latest News Read More  

The board of directors of the company, at its meeting held on Tuesday, has given in-principle approval for the fundraising proposal, Easy Trip Planners, which operates under the brand EaseMyTrip, the company said in a regulatory filing.

Indian rupee may rise to 81/$ by 2024 end amid robust inflow hopes: Goldman Sachs

Indian rupee may rise to 81/$ by 2024 end amid robust inflow hopes: Goldman Sachs

Still, the currency will underperform its Asian peers as the Reserve Bank of India (RBI) could continue to accumulate inflows and build forex reserves “at every opportunity,” economist Santanu Sengupta said.

Read More

​ Still, the currency will underperform its Asian peers as the Reserve Bank of India (RBI) could continue to accumulate inflows and build forex reserves “at every opportunity,” economist Santanu Sengupta said. Still, the currency will underperform its Asian peers as the Reserve Bank of India (RBI) could continue to accumulate inflows and build forex reserves “at every opportunity,” economist Santanu Sengupta said.  Moneycontrol Latest News Read More  

Still, the currency will underperform its Asian peers as the Reserve Bank of India (RBI) could continue to accumulate inflows and build forex reserves “at every opportunity,” economist Santanu Sengupta said.

Ashok Leyland skids 4% as sales hit speed-breaker in December

Ashok Leyland skids 4% as sales hit speed-breaker in December

Its light commercial vehicle segment also witnessed a drop, falling 6 percent during the month

Read More

​ Its light commercial vehicle segment also witnessed a drop, falling 6 percent during the month Its light commercial vehicle segment also witnessed a drop, falling 6 percent during the month  Moneycontrol Latest News Read More  

Its light commercial vehicle segment also witnessed a drop, falling 6 percent during the month

Russian oil cargoes head away from India amid payment issues

Russian oil cargoes head away from India amid payment issues

Five ships all carrying Sokol oil from Russia’s Far East — the NS Commander, Sakhalin Island, Krymsk, Nellis, and Liteyny Prospect — are moving toward the Malacca Strait at 7 to 10 knots, according to vessel-tracking data. A sixth also holding Sokol — the NS Century — is still close to Sri Lanka.

Read More

​ Five ships all carrying Sokol oil from Russia’s Far East — the NS Commander, Sakhalin Island, Krymsk, Nellis, and Liteyny Prospect — are moving toward the Malacca Strait at 7 to 10 knots, according to vessel-tracking data. A sixth also holding Sokol — the NS Century — is still close to Sri Lanka. Five ships all carrying Sokol oil from Russia’s Far East — the NS Commander, Sakhalin Island, Krymsk, Nellis, and Liteyny Prospect — are moving toward the Malacca Strait at 7 to 10 knots, according to vessel-tracking data. A sixth also holding Sokol — the NS Century — is still close to Sri Lanka.  Moneycontrol Latest News Read More  

Five ships all carrying Sokol oil from Russia’s Far East — the NS Commander, Sakhalin Island, Krymsk, Nellis, and Liteyny Prospect — are moving toward the Malacca Strait at 7 to 10 knots, according to vessel-tracking data. A sixth also holding Sokol — the NS Century — is still close to Sri Lanka.

Mid-day Mood | Profit booking seeps in as indices trade in red; pharma stocks shine

Mid-day Mood | Profit booking seeps in as indices trade in red; pharma stocks shine

Analysts had predicted a breather for the market as the sharp rally in the previous month had pushed the benchmarks into an overbought zone.

Read More

​ Analysts had predicted a breather for the market as the sharp rally in the previous month had pushed the benchmarks into an overbought zone. Analysts had predicted a breather for the market as the sharp rally in the previous month had pushed the benchmarks into an overbought zone.  Moneycontrol Latest News Read More  

Analysts had predicted a breather for the market as the sharp rally in the previous month had pushed the benchmarks into an overbought zone.

US FDA releases detailed observations at Torrent#39;s Chhatral unit; shares trade high

US FDA releases detailed observations at Torrent#39;s Chhatral unit; shares trade high

This was a Pre-Approval inspection conducted from 5 December to 11 December 2023.

Read More

​ This was a Pre-Approval inspection conducted from 5 December to 11 December 2023. This was a Pre-Approval inspection conducted from 5 December to 11 December 2023.  Moneycontrol Latest News Read More  

This was a Pre-Approval inspection conducted from 5 December to 11 December 2023.

US FDA releases detailed observations at Torrent#39;s Chhatral unit; shares trade high

US FDA releases detailed observations at Torrent#39;s Chhatral unit; shares trade high

This was a Pre-Approval inspection conducted from 5 December to 11 December 2023.

Read More

​ This was a Pre-Approval inspection conducted from 5 December to 11 December 2023. This was a Pre-Approval inspection conducted from 5 December to 11 December 2023.  Moneycontrol Latest News Read More  

This was a Pre-Approval inspection conducted from 5 December to 11 December 2023.

Rays Power Infra files draft papers to go public: Check details of solar power firm#39;s IPO

Rays Power Infra files draft papers to go public: Check details of solar power firm#39;s IPO

Rays Power Infra IPO: The public offer of the solar power company comprises a fresh issue of shares worth Rs 300 crore and an offer-for-sale of 29.95 lakh shares

Read More

​ Rays Power Infra IPO: The public offer of the solar power company comprises a fresh issue of shares worth Rs 300 crore and an offer-for-sale of 29.95 lakh shares Rays Power Infra IPO: The public offer of the solar power company comprises a fresh issue of shares worth Rs 300 crore and an offer-for-sale of 29.95 lakh shares  Moneycontrol Latest News Read More  

Rays Power Infra IPO: The public offer of the solar power company comprises a fresh issue of shares worth Rs 300 crore and an offer-for-sale of 29.95 lakh shares

Kay Cee Energy  Infra IPO subscribed 591 times on final day

Kay Cee Energy Infra IPO subscribed 591 times on final day

Kay Cee Energy Infra plans to raise Rs 15.93 crore through the IPO. It will use the net proceeds for working capital requirements worth Rs 13 crore and the remaining for general corporate purposes.

Read More

​ Kay Cee Energy Infra plans to raise Rs 15.93 crore through the IPO. It will use the net proceeds for working capital requirements worth Rs 13 crore and the remaining for general corporate purposes. Kay Cee Energy Infra plans to raise Rs 15.93 crore through the IPO. It will use the net proceeds for working capital requirements worth Rs 13 crore and the remaining for general corporate purposes.  Moneycontrol Latest News Read More  

Kay Cee Energy Infra plans to raise Rs 15.93 crore through the IPO. It will use the net proceeds for working capital requirements worth Rs 13 crore and the remaining for general corporate purposes.

Alembic Pharma shares surge 5% on USFDA product approvals

Alembic Pharma shares surge 5% on USFDA product approvals

Alembic Pharma is planning to launch over 20 products in the current financial year (FY24), with a focus on oral solids, injectables, and derma segments.

Read More

​ Alembic Pharma is planning to launch over 20 products in the current financial year (FY24), with a focus on oral solids, injectables, and derma segments. Alembic Pharma is planning to launch over 20 products in the current financial year (FY24), with a focus on oral solids, injectables, and derma segments.  Moneycontrol Latest News Read More  

Alembic Pharma is planning to launch over 20 products in the current financial year (FY24), with a focus on oral solids, injectables, and derma segments.

hi_INहिन्दी